Top Companies Report

48. Obagi

June 29, 2012

Long Beach, CA
562.628.1007
www.obagi.com
Sales: $114 million.
Net income: $10 million.

Key Personnel: Albert F. Hummel, president, director and chief executive officer; Preston S. Romm, chief financial officer and executive vice president of finance; David S. Goldstein, executive vice president, global sales and field marketing; Laura B. Hunter, vice president, general counsel and secretary.

Major Products: Dermatologist-based skin care systems including Nu-Derm, Professional-C, Elastiderm, Obagi-C Rx, Clenziderm and Rosaclear.

New Products: Elastiderm Eye Complete Complex Serum

Comments: Based on a 2011 study by Kline & Co., Obagi is the leading skin health company in the physician-dispensed channel, with an estimated 30.1% market share, nearly two times the market share of the next largest competitor.


Obagi’s topselling Nu-Derm range is turning 25 next year.
Obagi systems and products are designed to prevent and improve the most common and visible skin disorders in adult skin, including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, facial redness, and soft tissue deficits, such as fine lines and wrinkles. Products are sold through a direct sales force in the US and internationally through distribution partners in more than 43 countries across North America, Central America, Europe, the Middle East and Asia.

This year, for the second year in a row, Obagi Medical Products was named as the “The Best Skin-Care System at a Doctor’s Office” by New Beauty magazine.

“We are honored to be named, once again, the top skin care system from a physician’s office,” said Jim Hartman, vice president of global marketing and business development at Obagi Medical Products. “Being acknowledged in 2011 and now in 2012, by consumers, along with such an esteemed group of beauty insiders and industry professionals, makes it that much more significant.”

In 2013, The Obagi Nu-Derm System turns 25. It was launched in 1988 and consists of a combination of six prescription, OTC therapeutic agents and adjunctive cosmetic skin care products to treat visible skin conditions such as photodamage and hyperpigmentation resulting from extrinsic damage and intrinsic changes to the skin.

The Obagi Nu-Derm System accounted for approximately 53% of net sales for the year ended Dec. 31, 2011, according to the company.


 

Related End-User Markets:

blog comments powered by Disqus
  • Pushin’ the Cushion

    Pushin’ the Cushion

    Christine Esposito, Associate Editor||July 26, 2016
    AmorePacific, the creator of the cushion compact, continues to improve its unique product.

  • Senior Skin Care

    Senior Skin Care

    Christine Esposito, Associate Editor||July 19, 2016
    McCord Research and Product Quest Manufacturing roll out new hospital-grade skin care kits for seniors to use at home.

  • An Antioxidant Arsenal

    An Antioxidant Arsenal

    July 11, 2016
    BioRewind is Dermarché Labs' new anti-aging regimen that delivers broad-spectrum antioxidant protection against free radicals

  • Sustainability is Omnipresent

    Sustainability is Omnipresent

    Christine Esposito , Associate Editor||July 1, 2016
    Industry stakeholders convene in New York City for Organic Monitor’s annual event

  • Perceived Perfection

    Perceived Perfection

    Christine Esposito, Associate Editor||July 1, 2016
    From primers to pressed powders, facial cosmetics help create the illusion of a flawless complexion.

  • Preserve & Serve

    Preserve & Serve

    Melissa Meisel , Associate Editor||July 1, 2016
    Suppliers with innovative preservatives provide staying power for formulations.